Trial of Modafinil for Methamphetamine Dependence

Status Active, not recruiting

Clinical Trial Summary

The study aims to evaluate the safety and efficacy of modafinil (200 mg/day) over 10 weeks plus a tailored cognitive behavioural therapy program in the treatment of methamphetamine dependence.

Clinical Trial Description

Modafinil is a novel wake promoting agent approved in Australia for the treatment of narcolepsy. Preliminary studies have suggested that modafinil may have value in the treatment of psychostimulant dependence through positive effects on mood, sleep patterns, concentration, fatigue and drug craving. It appears to be well tolerated with a low abuse potential. Sixty dependent methamphetamine users will be allocated to 2 equal groups. The experimental group will receive modafinil 200 mg/day for 10 weeks and a tailored cognitive behavioural therapy program. The control group will receive placebo under equivalent conditions. Primary outcome will be a between group comparison of methamphetamine negative urine samples over the 10 week study period. Adverse events, side effects, compliance, retention and self reported health, psychosocial and drug use will also be compared between the study groups. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00123370
Study type	Interventional
Source	The University of New South Wales
Contact
Status	Active, not recruiting
Phase	Phase 2
Start date	July 2006
Completion date	September 2007

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT00600145` - Dose Response of Mirtazapine to Methamphetamine Induced Interest, Mood Elevation and Reward	N/A
Completed	`NCT00377299` - A Pilot Study of Citicoline add-on Therapy in Patients With Bipolar Disorder or Major Depressive Disorder and Amphetamine Abuse or Dependence	N/A
Recruiting	`NCT02541526` - Mirtazapine as a Treatment for Co-Occurring Opioid and ATS Dependence in Malaysia	Phase 3
Active, not recruiting	`NCT02541513` - An Open-label Study of Oral Paliparidone for the Treatment of Patients With Co-occurring Opioid and ATS Dependence	Phase 3
Completed	`NCT01100853` - Extended Release Naltrexone for Treating Amphetamine Dependence in Iceland	Phase 3
Completed	`NCT02774954` - Change the Cycle: An RCT to Prevent Injection Initiation	N/A
Not yet recruiting	`NCT01273701` - Combination of Psychosocial Intervention and Slow Prosecutions for the Treatment of Methamphetamine Abuse/Dependence	N/A
Completed	`NCT00833443` - Study of Medical Treatment for Methamphetamine Addiction	Phase 2
Active, not recruiting	`NCT00630097` - A Dose Ranging Study of Modafinil for Methamphetamine Dependence	Phase 2
Recruiting	`NCT02541500` - An Open Label Study of Oral Minocycline for the Treatment of Patients With Co-occurring Opioid and ATS Dependence	Phase 3